| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.71B | 23.48B | 21.96B | 21.79B | 19.75B | 18.60B |
| Gross Profit | 4.45B | 4.33B | 4.20B | 4.20B | 4.31B | 4.14B |
| EBITDA | 2.26B | 2.34B | 1.97B | 2.00B | 2.25B | 2.12B |
| Net Income | 835.00M | 944.00M | 1.06B | 902.00M | 1.06B | 946.46M |
Balance Sheet | ||||||
| Total Assets | 26.65B | 26.69B | 26.07B | 25.54B | 24.20B | 22.49B |
| Cash, Cash Equivalents and Short-Term Investments | 6.88B | 7.44B | 7.41B | 7.54B | 7.74B | 7.05B |
| Total Debt | 940.00M | 641.00M | 702.00M | 1.08B | 1.05B | 1.09B |
| Total Liabilities | 8.02B | 7.97B | 8.33B | 9.00B | 8.48B | 7.76B |
| Stockholders Equity | 18.57B | 18.66B | 17.68B | 16.50B | 15.68B | 14.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 433.00M | 486.00M | 100.00M | 987.00M | 1.24B |
| Operating Cash Flow | 0.00 | 2.16B | 1.86B | 1.24B | 1.75B | 1.68B |
| Investing Cash Flow | 0.00 | -1.77B | -1.35B | -1.12B | -642.00M | -416.22M |
| Financing Cash Flow | 0.00 | -388.00M | -642.00M | -333.00M | -337.00M | -336.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥547.04B | 13.65 | 6.55% | 2.71% | -0.06% | 137.47% | |
78 Outperform | ¥12.62B | 19.09 | ― | 4.54% | 4.38% | -12.68% | |
77 Outperform | ¥116.71B | 14.56 | 7.53% | 3.01% | 5.44% | 45.99% | |
76 Outperform | ¥76.90B | 12.49 | ― | 6.64% | 2.85% | -9.13% | |
70 Outperform | ¥159.38B | 7.06 | 10.46% | 2.35% | 4.56% | 49.23% | |
66 Neutral | ¥11.34B | 13.97 | ― | 4.20% | -5.73% | 20.76% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |